For the quarter ending 2025-09-30, NVAX has $1,179,889K in assets. $1,336,561K in debts. $268,023K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 268,023 | 253,744 | ||
| Marketable securities | 494,871 | 358,560 | ||
| Restricted cash | 10,816 | 10,749 | ||
| Accounts receivable | 34,174 | 226,396 | ||
| Inventory | 13,511 | 10,240 | ||
| Prepaid expenses and other current assets | 45,532 | 59,823 | ||
| Assets held for sale | 107,663 | - | ||
| Total current assets | 974,590 | 919,512 | ||
| Property and equipment, net | 49,120 | 129,643 | ||
| Right of use asset, net | 23,873 | 153,044 | ||
| Goodwill | 113,080 | 112,958 | ||
| Other non-current assets | 19,226 | 21,392 | ||
| Total assets | 1,179,889 | 1,336,549 | ||
| Accounts payable | 15,227 | 50,595 | ||
| Accrued expenses | 115,586 | 86,697 | ||
| Deferred revenue | 104,251 | 113,763 | ||
| Current portion of finance lease liabilities | 5,036 | 5,552 | ||
| Other current liabilities | 138,334 | 132,531 | ||
| Liabilities held for sale | 51,435 | - | ||
| Total current liabilities | 429,869 | 389,138 | ||
| Deferred revenue | 397,105 | 399,263 | ||
| Convertible notes payable | 243,835 | 170,568 | ||
| Non-current finance lease liabilities | 2,269 | 52,370 | ||
| Other non-current liabilities | 263,483 | 287,585 | ||
| Total liabilities | 1,336,561 | 1,298,924 | ||
| Common stock, 0.01 par value, 600,000,000 shares authorized at september30, 2025 and december31, 2024 164,817,266 shares issued and 162,470,138 shares outstanding at september30, 2025 and 161,942,677 shares issued and 160,421,136 shares outstanding at december31, 2024 | 1,648 | 1,645 | ||
| Additional paid-in capital | 4,531,763 | 4,522,193 | ||
| Accumulated deficit | -4,585,675 | -4,383,296 | ||
| Treasury stock, cost basis, 2,347,128 shares at september30, 2025 and 1,521,541 shares at december31, 2024 | 102,663 | 102,459 | ||
| Accumulated other comprehensive loss | -1,745 | -458 | ||
| Total stockholders deficit | -156,672 | 37,625 | ||
| Total liabilities and stockholders deficit | 1,179,889 | 1,336,549 | ||
NOVAVAX INC (NVAX)
NOVAVAX INC (NVAX)